tiprankstipranks
Jazz Pharmaceuticals Relocates Operations to New Premises
Company Announcements

Jazz Pharmaceuticals Relocates Operations to New Premises

Don't Miss our Black Friday Offers:

Jazz Pharmaceuticals ( (JAZZ) ) has provided an update.

Jazz Pharmaceuticals is set to relocate its operations in Palo Alto following a new lease agreement with Hudson Palo Alto Square, LLC. This move comes after securing a tenant to relet their current premises, allowing for an effective lease termination by mid-2025. This strategic shift ensures Jazz continues its U.S. operations smoothly across key locations.

For detailed information about JAZZ stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyFDA grants accelerated approval to Jazz Pharmaceuticals’ Ziihera
TheFlyJazz Pharmaceuticals price target lowered to $163 from $166 at Piper Sandler
TheFlyZymeworks, Jazz Pharmaceuticals announce FDA approval of Ziihera
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App